Latin America Pharmaceutical Contract Manufacturing And Research Services Market To Reach $37.2 Billion By 2033

Latin America Pharmaceutical Contract Manufacturing And Research Services Market Growth & Trends

The Latin America pharmaceutical contract manufacturing and research services market size is anticipated to reach USD 37.2 billion by 2033, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.1% from 2026 to 2033. The low manufacturing costs and growing demand for generics are the key factors driving the market growth. Moreover, factors, such as the growing pharmaceutical industry, rising investments in R&D, and technological advancements, are responsible for market growth. The shift from cost control to value-added solutions, the introduction of novel technologically equipped facilities, and risk-sharing between pharma and CMOs are also contributing to the industry growth.

Companies have started financing efforts to meet the rising demand for biological drugs, which, in turn, leads to an increase in the development of pharmaceutical products. This steady commercial success of biopharmaceuticals is expected to accelerate the growth of the regional market for pharmaceutical contract manufacturing & research services over the forecast period. Pharmaceutical contract manufacturing and research activities in Brazil are subject to severe requirements to maintain Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) compliance. These laws cover a wide range of topics, such as facility requirements, quality control systems, documentation practices, and employee qualifications.

Contract manufacturing and research companies must receive the relevant authorizations and certificates from ANVISA, which includes a thorough review of their facilities, processes, and quality management systems. Technological advances in areas, such as biopharmaceutics, personalized medicine, and analytical methods, have increased the complexity of drug production and research processes. Outsourcing these functions to specialist contract service providers in Latin America can provide access to state-of-the-art facilities and expertise.

 Request a free sample copy or view report summary: Latin America Pharmaceutical Contract Manufacturing & Research Services Market Report

Latin America Pharmaceutical Contract Manufacturing And Research Services Market Report Highlights

• Manufacturing services dominated the market with the largest share of 66.3% in 2025. Based on services, the market is segmented into manufacturing and research. Contract manufacturing services comprise the solutions and facilities for the production of API/bulk drugs, advanced drug delivery formulations, packaging, and finished dose formulations

• Brazil accounted for the largest revenue share of 69.4% in 2025. The low manufacturing costs of pharmaceuticals and the presence of a significant number of GMP-certified plants are attracting investors from other countries to establish their presence in Brazil

• The research service segment is expected to grow significantly during the forecast period. Research services in the Latin American pharmaceutical contract manufacturing and research services market involve a range of offerings from CROs, including preclinical, clinical, and formulation development support.

• Key players have undertaken various growth strategies, such as business expansion, mergers, and acquisitions, to gain higher market shares. For instance, in September 2020, Charles River Laboratories Inc. announced that it has opened a microbial identification lab in Brazil

Latin America Pharmaceutical Contract Manufacturing And Research Services Market Segmentation

Grand View Research has segmented the Latin America pharmaceutical contract manufacturing & research services market report based on service and region.

Latin America Pharmaceutical Contract Manufacturing And Research Services Service Outlook (Revenue, USD Million, 2021 - 2033)

• Manufacturing

  • API/Bulk Drugs

  • Advanced Drug Delivery Formulations

  • Packaging

  • Finished Dose Formulations

    • Solid

    • Liquid

    • Semi-solid Formulations

• Research

  • Oncology

  • Vaccines

  • Inflammation & Immunology

  • Cardiology

  • Neuroscience

  • Others

Latin America Pharmaceutical Contract Manufacturing And Research Services Regional Outlook (Revenue, USD Million, 2021 - 2033)

• Latin America

  • Brazil

  • Colombia

  • Argentina

  • Chile

  • Venezuela

  • Peru

  • Uruguay

  • Ecuador

  • Bolivia

List Of Key Players in the Latin America Pharmaceutical Contract Manufacturing And Research Services Market

• Boehringer Ingelheim International GmbH

• Fresenius Kabi AG

• Unither Pharmaceuticals

• Lonza

• Pfizer Inc.

• Charles River Laboratories

• Laboratory Corporation of America Holdings

• IQVIA, Inc.

• Recipharm AB.

• AbbVie, Inc.

• Catalent, Inc.

• West Pharmaceutical Services, Inc.